Verified July 2026 · Cited to primary sources

Semax: Evidence Grade C — Early / foreign human data only.

Grade CUnder FDA reviewSafety: amber

The honest verdict

Semax is not FDA-approved (it is approved in Russia) and is under FDA review (July 24, 2026 PCAC). Human evidence is Grade C — real Russian trials, but no Western replication. For the anxiety-focused sister peptide, see our Selank page and our cognitive-peptides hub.

Semax at a glance

Class
Synthetic heptapeptide (nootropic)
Mechanism
Modulates BDNF and dopaminergic/serotonergic systems — a neuroprotective, cognition-enhancing nootropic peptide.
Also known as
ACTH(4-10) analog, Met-Glu-His-Phe-Pro-Gly-Pro
Research applications
  • Cognition and focus / brain fog (Russian clinical use)
  • Ischemic stroke recovery and neuroprotection (Russian trials)
Forms
intranasal spray/drops
Legal status
Under FDA review
WADA (anti-doping)
Not prohibited (occasionally monitored — verify)
Evidence grade
Grade CEarly / foreign human data only

How we grade evidence

Every grade is assigned by a fixed A–F rubric — human-trial strength, not hype or affiliate status. Last verified July 6, 2026.

What is Semax?

A Russian-approved cognitive/neuroprotective peptide with real but non-Western clinical data.

Modulates BDNF and dopaminergic/serotonergic systems — a neuroprotective, cognition-enhancing nootropic peptide.

How strong is the evidence for Semax?

Grade C: approved as a drug in Russia with Russian clinical studies (stroke, cognition), but no rigorous Western RCT replication (rule 4 fired — foreign approval with weak/unreplicated RCTs).

Primary sources (2)

  1. FDA PCAC July 23–24, 2026 meeting (docket, July 24)
  2. Federal Register FDA-2025-N-6895 (April 2026 503A reclassification)

What is Semax used for?

Semax is marketed for the goals below. See how it ranks against other peptides in each — by evidence, not hype.

Best peptides for Cognition & Focus →

What does Semax cost — and how do you access it legally?

Typical cost

UNKNOWN

No verified US clinic price anchor in the research; marked UNKNOWN.

No legal supervised access route right now.

Semax has no compliant US route today while its compounding status is under FDA review. Vials sold "for research use only" are a gray-market fig-leaf, not a legal loophole — we don't link them. If you pursue Semax, do it with a licensed clinician, and re-check its legal status first.

Is Semaxsafe? Side effects & risks

Limited human safety data, no major documented harms

Safety data largely limited to Russian post-marketing use; long-term Western safety profile unknown. Not on the WADA list (verify; occasionally monitored).

Medical disclaimer: This page is independent editorial information, not medical advice, and Best Peptide For That is not a medical provider. We do not provide dosing. Talk to a licensed clinician before starting, stopping, or changing any peptide or medication. Full medical disclaimer.

FAQ

Semax FAQ

Is Semax approved anywhere?

Yes — Semax is an approved drug in Russia and has Russian clinical studies for stroke recovery and cognition. It is not FDA-approved, and those trials have not been replicated to Western RCT standards, so we grade it C.

Is Semax on the FDA peptide docket?

Yes. Semax is one of the seven peptides the FDA's Pharmacy Compounding Advisory Committee reviews on July 24, 2026.

Is Semax the same as Selank?

No, but they're close cousins — both Russian-developed peptides with real but non-Western human data (both Grade C). Semax is the cognition/neuroprotection peptide; Selank is the anti-anxiety/anti-stress peptide. See our cognitive-peptides hub for the side-by-side.

Compare Semax with…

Head-to-head evidence-grade matchups people weigh against Semax.

Keep reading

Grade C

Selank

A Russian-developed anti-anxiety and nootropic peptide with real but non-Western human trials — in Russian studies it matched a benzodiazepine for anxiety without the sedation or dependence.

Grade A

Tesamorelin

One of only two FDA-approved peptides in this space — proven to cut visceral fat, but approved for a narrow HIV indication.

Grade A

PT-141

One of only two FDA-approved peptides in this space — proven to raise sexual desire in premenopausal women, but the benefit is modest and the off-label hype outruns it.

How we grade the evidence →Are peptides safe? →FDA peptide status 2026 →

The monthly peptide evidence brief.

What the research and the FDA actually say — one short email a month. Unsubscribe anytime.

No spam. We never sell your email. Editorial policy.